Nerve Growth Factor Market Forecast Highlights Expansion From $1.27 Billion To $1.71 Billion Through 2030
Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Nerve Growth Factor Market Size Outlook: How Fast Will Revenue Grow Through 2030?
The market for nerve growth factor has seen notable expansion in recent years. From $1.19 billion in 2025, it is projected to reach $1.28 billion in 2026, driven by a 7.6% compound annual growth rate. Historical growth can be explained by several factors, including breakthroughs in neurobiology studies, the clinical advancement of cenegermin, a rising incidence of neurological conditions, broader use of ophthalmology therapies, and expansion in biologics manufacturing.
The market for nerve growth factor is anticipated to experience robust expansion over the coming years. By 2030, its value is projected to reach $1.71 billion, driven by a compound annual growth rate (CAGR) of 7.6%. This forecasted growth is fueled by several factors, including a higher prevalence of neurodegenerative conditions, the advancement of regenerative medicine initiatives, an uptick in clinical trials focused on nerve restoration, increased funding for biologics research and development, and breakthroughs in NGF delivery methods. Key trends shaping this period encompass heightened research into neuroregeneration therapies, a greater emphasis on treating neurodegenerative diseases, the growing application of recombinant protein therapeutics, expanded clinical usage in ophthalmic conditions, and rising investment in technologies for nerve repair.
Download A Free Sample Report For Comprehensive Market Insights:
Nerve Growth Factor Market Expansion Supported By Key Demand Factors
The market for nerve growth factors is anticipated to expand due to the rising incidence of neurological disorders. These conditions, which impact the brain, spinal cord, and nerves, stem from structural, biochemical, or electrical irregularities. Their growing frequency is driven by aging populations and enhanced diagnostic technologies, which improve detection and reporting, thus boosting documented case numbers. Nerve growth factor (NGF) is vital for neuronal maintenance, survival, and regeneration, positioning it as a key element in managing these disorders by supporting neural repair and possibly decelerating disease progression. As an illustration, the Australian Institute of Health and Welfare, a government body in Australia, reported in September 2024 that dementia cases—a neurological disorder—are expected to climb from roughly 411,100 in 2023 to 849,300 by 2058. Consequently, the escalating frequency of neurological disorders is fueling the nerve growth factor market’s advancement.
Nerve Growth Factor Market Segment Analysis Highlighting Growth Areas
The nerve growth factor market covered in this report is segmented –
1) By Type: Alpha-Nerve Growth Factor (NGF), Beta-Nerve Growth Factor (NGF), Gamma-Nerve Growth Factor (NGF), Other Types
2) By Agents: Cenegermin, Other Agents
3) By Indication: Neurodegenerative Disorders, Spinal Cord Injuries, Eye Disorders, Epithelial Diseases, Tissue Healing, Other Indications
4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
5) By End-User: Hospitals, Homecare, Specialty Clinics, Other End-Users
Subsegments:
1) By Alpha-Nerve Growth Factor (a-NGF): Natural Alpha-NGF, Recombinant Alpha-NGF, Synthetic Alpha-NGF, Alpha-NGF For Research Applications
2) By Beta-Nerve Growth Factor (ß-NGF): Human Beta-NGF, Animal-Derived Beta-NGF, Recombinant Beta-NGF, Therapeutic Beta-NGF, Research-Grade Beta-NGF
3) By Gamma-Nerve Growth Factor (?-NGF): Natural Gamma-NGF, Recombinant Gamma-NGF, Synthetic Gamma-NGF, Gamma-NGF for Neurodegenerative Research
4) By Other Types: Hybrid NGF Molecules, NGF Mimetics, NGF Gene Therapy-Based Products, NGF-Infused Biomaterials
Nerve Growth Factor Market Growth Trends Influencing Competitive Dynamics
Major players in the nerve growth factor sector are concentrating their efforts on the creation of biologic treatments that target NGF, including anti-NGF monoclonal antibodies engineered to block NGF activity and alleviate persistent pain. By binding to nerve growth factor, an anti-NGF monoclonal antibody prevents the activation of its receptors, thereby diminishing pain signaling and inflammatory reactions in individuals suffering from degenerative or neuropathic disorders. For example, in May 2023, Jiangsu Hengrui Pharmaceuticals, a biopharmaceutical firm based in China, launched SHR-1314, an advanced anti-NGF monoclonal antibody now undergoing clinical trial registration for managing osteoarthritis-related pain. This therapy boasts a highly specific binding mechanism that curbs NGF-driven sensitization, along with an extended serum half-life enabling reduced dosing intervals, with a goal of providing lasting pain relief for those affected by chronic joint conditions.
Nerve Growth Factor Market Leading Companies: Who Holds Significant Market Presence?
Major companies operating in the nerve growth factor market are Dompé farmaceutici S.p.A., Regeneron Pharmaceuticals Inc., Mimetogen Pharmaceuticals, MimeTech Srl, Herantis Pharma, PainCeptor Pharma, Beike Biotechnology, Akeso Inc., Promega Corporation, Enzo Life Sciences Inc., Alomone Labs, Prospec-Tany Technogene Ltd., CUSABIO Technology LLC, Genexis Biotech Pvt. Ltd., Staidson Beijing BioPharmaceuticals, Biomol GmbH, Sino Biological Inc., PeproTech Inc., Abcam plc, Creative BioMart Inc.
Access The Complete Nerve Growth Factor Market Report:
Nerve Growth Factor Market Global Footprint: Which Region Holds Market Leadership?
Asia-Pacific was the largest region in the nerve growth factor market in 2025. The regions covered in the nerve growth factor market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
